Interestingly, there was no significant difference in the expression of TP53-inhibiting protein Mdm2 (Figure 3E), suggesting that TP53 expression was being specifically altered in the PTSD group, independent of other confounding factors or regulatory mechanisms related to TP53. Here, MDM2 is linked to post-traumatic stress disorder.